Prognostic value of PD-L1 expression in patients with pancreatic cancer: A PRISMA-compliant meta-analysis.

Hu, Ying; Chen, Wanzhen; Yan, Zhanpeng; Ma, Jingxia; Zhu, Fangshi; Huo, Jiege

Hu, Ying; Chen, Wanzhen; Yan, Zhanpeng; Ma, Jingxia; Zhu, Fangshi; Huo, Jiege.

Afiliação

Hu Y; Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China.
Chen W; Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China.
Yan Z; Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing 210028, Jiangsu Province, China.
Ma J; Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China.
Zhu F; Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, Jiangsu Province, China.
Huo J; Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing 210028, Jiangsu Province, China.

Medicine (Baltimore) ; 98(3): e14006, 2019 Jan.

Article em En | MEDLINE | ID: mdl-30653106

Assuntos

Antígeno B7-H1/metabolismo; Neoplasias Pancreáticas/metabolismo; Adulto; Idoso; Biomarcadores Tumorais/metabolismo; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Estadiamento de Neoplasias; Razão de Chances; Neoplasias Pancreáticas/patologia; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antígeno B7-H1 Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Antígeno B7-H1 Idioma: En Ano de publicação: 2019 Tipo de documento: Article